Insights

Emerging deep tech like biotechnology and synthetic biology are shaping an exciting new bioeconomy. This CC Innovation Briefing offers a vision for its future, and explains how scalable, profitable and resilient bioprocesses will benefit businesses and sustainability.

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

The digital future of ophthalmology comes with the promise of improved patient access, better quality of care, reduced workloads, optimised efficiencies and improved quality of life for patients and HCPs. There are many challenges to be overcome, not least the need to develop data, workflows and technologies in tandem. One example core example is how to best unlock successful home monitoring for ophthalmology…

With transformative opportunities in biological products and sustainable biofuels on the horizon, the agritech industry needs to work together to achieve commercial success and realise environmental advantages. Fresh from his visit to the World Agri-Tech Innovation Summit in San Francisco, Niall Mottram calls for actions to back up the promising rhetoric...

In the world of bioprocessing engineering, companies developing cultured meat and other cultured ingredients face both technical and financial challenges at each step up in scale. Here, Steve Thomas and James Westley explain how sophisticated predictive models – digital twins – that couple biology, heat transfer, mass transfer and fluid dynamics can help… 

A meeting of minds - AI meets biology. This is the conversation that is bridging the gap between bioprocessing and machine learning.

The future of smart implantable medical devices – Our experts share key insights for medical implant manufacturers.

Asia’s medical technology market is predicted to account for a third of global medical technology sales by 2025. As such, it's a hotbed for start-ups, so here are our six innovative start-ups to watch that are part of this year’s MedTech Innovator cohort. 

Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. It is a biomarker that Cell4D is using to screen and sort live cells

Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.

Founders of early-stage start-ups are characteristically passionate, driven and optimistic. Understandably so. Very often they are nurturing a breakthrough idea with the capacity to disrupt business and change the world for the better. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.